The uniform approach to breast fine-needle aspiration biopsy

Diagnostic Cytopathology

Volumn 16, Issue 4, 1997, Pages 295-311

  Silverman, J ^a   Sneige, N ^a   Stahl, R E ^a   Stanley, M ^a   Thomas, P ^a   Vazquez, M ^a   Waisman, J ^a   Wolman, S ^a   Worsham, G F ^a   Wunderlich, C ^a   Yawn, B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION BIOPSY; BENIGN TUMOR; BREAST BIOPSY; BREAST TUMOR; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NEEDLE BIOPSY; PRIORITY JOURNAL; REVIEW; TUMOR DIAGNOSIS;

BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS;

EID: 15444351796     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(1997)16:4<295::AID-DC1>3.0.CO;2-D     Document Type: Review

References (91)

1. Abele JS, Miller TR. Implementation of an outpatient needle aspiration biopsy service and clinic: A personal perspective. In: Schmidt W, ed. Cytopathology annual. Baltimore: Williams & Wilkins, 1993:43-71.
2. Abele JS, Miller TR, Goodson WH, et al. Fine-needle aspiration of palpable breast masses: a program for staged implementation. Arch Surg 1983;118: 859-863.
3. Abu-Farsakh H, Sneige N, Atkinson EN, Hortobagyi G. Pathologic predictors of tumor response to preoperative chemotherapy in locally advanced breast carcinoma. Breast J 1995;1:96-101.
4. Al-Kaisi N. The spectrum of "gray zone" in breast cytology. A review of 186 cases of atypical and suspicious cytology. Acta Cytol 1994;38:898-908.
5. Alien MJ, Thompsin WD, Stuart RC, Gill PT, et al. Management of non-palpable breast lesions detected mammographically. Br J Surg 1994;81: 543-545.
6. American Joint Committee on Cancer. Manual for staging for breast carcinoma. 3rd ed. 1989.
7. Azzarelli A, Guzzon A, Pilotti S, et al. Accuracy of breast cancer diagnosis by physical, radiologie and cytologic combined examinations. Tumori 1983;69:137-141.
8. Barrows GH, Anderson TJ, Lamb JL, et al. Fine-needle aspiration of breast cancer: relationship of clinical factors to cytology results in 689 primary malignancies. Cancer 1986;88:1493-1498.
9. Blume E, Artz D. Too many breast biopsies? Watching vs. Cutting. J Natl Cancer Inst 1991;83:1207-1209.
10. Bondeson L, Lindholm K. Aspiration cytology of tubular breast carcinoma. Acta Cytol 1990;34:15-20.
11. Bottles K, Miller TR, Cohen MB, et al. Fine needle aspiration biopsy. Has its time come? Am J Med 1986;81:525-531.
12. Cohen MB, Miller TR, Gonzales JM, et al. Fine-needle aspiration biopsy. Lab Med 1986;110:813-817.
13. Cohen MB, Rodgers C, Hales MS, et al. Influence of training and experience in fine-needle aspiration biopsy of breast: receiver operating perceptions of physicians at an academic medical enter. Archives of Pathology characteristics curve analysis. Arch Pathol Lab Med 1987;111: 518-520.
14. Dabbs DJ, Silverman JF. Prognostic factors from the fine needle aspirate: breast carcinoma nuclear grade. Diagn Cytopathol 1994;10:203-208.
15. Dawson AE, Norton JA, Weinberg DS. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol 1990;136;1115-1124.
16. DiPietro S' Fariselle G, Bandieramonte G, et al. Diagnostic efficacy of the clinical-radiological-cytological triad in solid breast lumps: results of a second prospective study on 631 patients. Eur J Surg Oncol 1987;13:335-340.
17. Dixon JM, Andreson TJ, Lamb J, Nixon SJ, Forrest AP. Fine needle aspiration cytology, in relationships to clinical examination and mammography in the diagnosis of a solid breast mass. Br J Surg 1984;71:593-596.
18. Dupont WD, Page DL. Risk factors for women with proliferative breast disease. N Engl J Med 1985;312;145-151.
19. Elledge RM, Allred DC. The p53 tumor suppressor gene in breast cancer. Breast Cancer Res Treat 1994;32:39-47.
20. 3. J Ultrasound Med 1990;9:559-568.
21. Frable WJ. Needle aspiration of the breast. Cancer 1984;53:671-676.
22. Frable WJ. Needle aspiration biopsy. Past, present and future. Hum Pathol 1989;20:504-517.
23. Giard RWM, Hermans J. The value of aspiration cytologic examination of the breast. A statistical review of the medical literature. Cancer 1992;69: 2104-2110.
24. Goldhirsch A, Wood WC, Senn HJ, et al. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 1995;87:1441-1445.
25. Goodson WH, Mailman R, Miller TR. Three-year follow up of benign fine needle aspiration biopsies of the breast. Am J Surg 1987;154:58-61.
26. Hahn P, Hallberg O, Schnurer LB. Combination of clinical examination, mammography and aspiration cytology in the diagnosis of carcinoma of ther breast (179 cases). Strahlentherapie 1980;156:475-479.
27. Harris MW. Personal communication to William H. Goodson, M.D., University of California, San Francisco, July 21, 1988.
28. Hartlaub PP, Wokenstein AS, Laufenburg HF. Obtaining informed consent: it is not simply asking "Do you understand?" J Fam Pract 1993;36:383-384.
29. Hermansen C, Poulsen HS, Jensen J, et al. Diagnostic reliability of combined physical examination, mammography, and fine-needle puncture ("Triple-Test") in breast tumors: a prospective study. Cancer 1987;60:1866-1871.
30. Heuftle MG, Haaga JR. Effect of suction on biopsy sample size. AJR 1986;147:1014-1016.
31. Idvall I, Ferno M, Sigurdsson H, Akerman M, Killander D. Fine needle aspiration cytology of breast carcinoma: a pre-operative prognostic tool? Breast 1995;4:189-195.
32. Ilke F, Veronesi U, Luini A, et al. Preoperative chemotherapy alone and combined with preoperative radiotherapy in small-size breast cancer. Breast J 1996;2:176-180.
33. Jackman RJ, Nowels KW, Shepard MJ, et al. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994;193:91-95.
34. Joensuu H, Alanen K, Falkmer UG, et al. Effect of DNA ploidy classification on prognosis in breast cancer. Int J Cancer 1992;52:701-706.
35. Kaufman Z, Shpitz B, Shapiro M, Rona R, Lew S, Dinbar A. Triple approach in the diagnosis of dominant breast masses: combined physical examination, mammography and fine-needle aspiration. J Surg Oncol 1994;56:254-257.
36. Kline TS, Kline IK. High risk lesion. In: Guides to clinical aspiration biopsy. New York: Igaku-Shoin 1989:235-248.
37. Koss LG, Woyke S, Olszewski W. Aspiration biopsy: cytologic interpretation and histologic bases. New York: Igaku-Shoin, 1984:53-104.
38. Koss LG, Woyke S, Olszewski W. Aspiration biopsy: cytologic interpretation and histologic basis. 2nd ed. New York: Igaku-Shoin, 1992:12-27.
39. Kreuzer G, Boqui E. Aspiration biopsy cytology, mammography and clinical exploration: a modern set up in diagnosis of tumors of the breast. Acta Cytol 1976;20:319-323.
40. Lannin DR, Silverman JF, Pories WJ, et al. Cost-effectiveness of fine needle biopsy of the breast. Ann Surg 1986;203:474-480.
41. Layfield LJ. Can fine-needle aspiraton replace open biopsy in the diagnosis of palpable breast lesions? Am J Clin Pathol 1992;98:145-147.
42. Layfield LJ, Chrischilles EA, Cohen MB, et al. The palpable breast nodule. A cost-effectiveness analysis of alternate diagnostic approaches. Cancer 1993;72:1642-1651.
43. Layfield LJ, Glasgow BJ, Cramer H. Fine needle aspiration in the management of breast masses. In: Rosen PP, Fechner R, eds. Pathology annual: nineteen eight-nine. Part II. Norwalk, Connecticut: Appleton and Lange, 1989:23-62.
44. Layfield LJ, Parkinson B, Wong J, Giuliano AE, Bassett LW. Mammographically guided fine-needle aspiration biopsy of nonpalpable breast lesions. Can it replace open biopsy? Cancer 1991;68:2007-2011.
45. Lee KR, Foster RS, Papillo JL. Fine needle aspiration of the breast: importance of the aspirator. Acta Cytol 1987;31:281-284.
46. Liberman L, Cohen MA, Dershaw DD, et al. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR 1995;164:1111-1113.
47. Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic 14-gauge breast biopsy: how many core biopsy specimens are needed? Radiology 1994;192:793-795.
48. Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic core biopsy of breast carcinoma: accuracy in predicting invasion. Radiology 1995;194:379-381.
49. Linsk J, Kruezer G, Zajicek J. Cytologic diagnosis in mammary tumors from aspiration biopsy smears. II. Studies on 210 fibroadenomas and 210 cases of benign dysplasia. Acta Cytol 1972;16:130-138.
50. Lotan R, Xu XC, Lippman SM, et al. Suppression of retinoic acid receptor B in premalignant oral lesions and its upregulation by isotretinoin. N Engl J Med 1995;332:1405-1410.
51. Mansour EG, Ravdin PM, Dressier L. Prognostic factors in early breast carcinoma. Cancer Suppl 1994;74:381-400.
52. Martelli G, Pilotti S. Diagnostic efficiency of physical examination, mammography, fine-needle aspiration cytology (triple-test) in solid breast lumps: an analysis of 1708 consecutive cases. Tumori 1990;76:476-479.
53. Masood S. Cytopathology of the breast. Chicago: ASCP Press, 1996.
54. Masood S. Pathological interpretation of fine needle aspiration cytology. In: Fajardo, Willison, Pizutiello, eds. A comprehensive approach to stereotactic breast biopsy. Cambridge, MA: Blackwell Science, 1996:225-239.
55. Masood S, Frykberg ER, McLellan GL, et al. Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates. Diagn Cytopathol 1991;7:581-590.
56. Masood S, Frykberg ER, McLellan GL, et al. Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions. Cancer 1990;66:1480-1487.
57. Maygarden SJ, Novotny DB, Johnson DE, et al. Subclassification of benign breast disease by fine needle aspiration cytology: comparison of cytologic and histologic findings in 265 palpable breast masses. Acta Cytol 1994;38:115-129.
58. Meyer JE, Kopans DB. Analysis of mammographically obvious carcinomas of the breast with benign results on initial biopsy. SGO 1981;153:153-157.
59. Mitnick J, Roses D, Harris M. A differentiation of post surgical changes from carcinoma of the breasl. SGO 1988;166:549-550.
60. Mitnick JS, Vazquez MF, Narris MN, et al. Differentiation of radial scar from cirrhous carcinoma of the breast: mammographic-pathologic correlation. Radiology 1989;173:697-700.
61. Mulford DK, Dawson AE. Atypia in fine needle aspiration cytology of nonpalpable and palpable mammographically detected breast lesions. Acta Cytol 1994;38:9-17.
62. Muss HB, Thor AD, Berry DA, et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 1994;330:1260-1266.
63. O'Reilly SM, Camplejohn RS, Barnes RR, Millis RR, Rubens RD, Richards MA. Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry. J Clin Oncol 8:2040-2046, 1990.
64. Orell S. Fine needle aspiration biopsy in perspective (editorial). Pathology 1982;14:113-114.
65. O'Shaughnessy JA. Chemoprevention of breast cancer. JAMA 1996;275: 1349-1352.
66. Palombini L, Fulciniti F, Vetrani A, et al. Fine-needle aspiration biopsies of breast masses. A critical analysis of 1956 cases in 8 years (1976-1984). Cancer 1988;61:2273-2277.
67. Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional siudy. Radiology 1994;193:359-364.
68. Parker SH, Stavros AT. Needle biopsy techniques. Radiol Clin North Am 1995;33:1171-1186.
69. Pennes DR, Naylor B, Rebner M. Fine needle aspiration biopsy of the breast. Acta Cytol 1989;34:673-676.
70. Pinder SE, Wencyk P, Sibbering DM, et al. Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: association with other prognostic factors and survival. Br J Breast Cancer 1994;53:146-149.
71. Porter-Jordan K, Lippman ME. Overview of the biologic markers of breast cancer. Hematol Oncol Clin North Am 1994;8:73-100.
72. Ravdin PM, Chamness GC. The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers - a review. Gene 1995;159:19-27.
73. Reiner A, Reiner G, Spona J, Teleky B, Kolb R, Holzner JH. Estrogen receptor immunocytochemistry for preoperative determination of estrogen receptor status on fine needle aspirates of breast cancer. Am J Clin Pathol 1987;88:399-404.
74. Robinson JA, McKee G, Nichols A. D'Arcy J, Jackson PA, Cook MG, Kissin MW. Prognostic value of cytological grading of fine needle aspirates from breast carcinomas. Lancet 1994;343:947-949.
75. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991;15:209-221.
76. Rotstein S, Nilsson B, Svane G, Gustavson-Kadaka E. Clinical examination, mammographic findings and cytological diagnosis in patients with breast disorders. Results of 9 years follow-up. Acta Oncol 1992;31:393-397.
77. Silverman J. Breast. In: Bibbo M, ed. Comprehensive cytopathology. Philadelphia: WB Saunders, 1991, pp 703-770.
78. Silverman JF, Lannin DR, O'Brien K, et al. The triage role of fine needle aspiration biopsy of palpable breast masses. Diagnostic accuracy and cost-effectiveness. Acta Cytol 1987;31:731-736.
79. Silverman JF, Masood S, Ducatman BS, Wang HH, Sneige N, Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast: cytomorphologic criteria and limitations in diagnosis. Diagn Cytopathol 1993;9:713-728.
80. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma. Cancer 1994;73:664-667.
81. Sneige N. A comparison of fine-needle aspiration, core biopsy and needle localization biopsy techniques in mammographically detectable nonpalpable breast lesions. Pathol Case Rev 1996;1:6-11.
82. Sneige N. Current issues in fine needle aspiration of the breast: cytologic features of in situ lobular and ductal carcinomas and clinical implications of nuclear grading. Cytopathol Annu 1992;7:155-171.
83. Sneige N, Staerkel GA. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ. Hum Pathol 1994;25:485-492.
84. Stanley MW, Abele JS. Malpractice vs. benepractice (letter; comment). Am J Surg Pathol 1995;19:483-485.
85. Stanley MW, Henry MJ, Zera R. Atypia in breast fine-needle aspiration smears correlates poorly with the presence of a prognostically significant proliferative lesion of ductal epithelium. Human Pathol 1993;4:630-635.
86. Stanley MW, Lowhagen T. Fine-needle aspiration of palpable masses. Boston: Butterworth-Heinemann, 1993.
87. Ulanow R, Galblum L, Canter JW. Fine needle aspiration in the diagnosis and management of solid breast lesions. Am J Surg 1984;148:6653-657.
88. Vetto J, Pommier R, Schmidt W, et al. Use of the "Triple Test" for palpable breast lesions yields high diagnostic accuracy and cost savings. Am J Surg 1995;169:519-522.
89. Vural G, Hagmar B, Lilleng R. A one-year audit of fine needle aspiration cytology of breast lesions. Factors affecting adequacy and a review of delayed carcinoma diagnoses. Acta Cytol 1995;39:1233-1236.
90. Zajdela A, Zillhardt P, Voillemot N. Cytological diagnosis by fine needle sampling without aspiration. Cancer 1987;59:1201-1205.
91. Zarbo RJ, Howanitz PJ, Bachner P. Interinstitutional comparison of performance in breast fine-needle aspiration cytology. Arch Pathol Lab Med 1991;115:743-750.